These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
675 related articles for article (PubMed ID: 29239017)
1. Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma. Song J; Xu Q; Zhang H; Yin X; Zhu C; Zhao K; Zhu J J Cell Biochem; 2018 Jun; 119(6):4559-4569. PubMed ID: 29239017 [TBL] [Abstract][Full Text] [Related]
2. N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma. Hu Y; Chen Y Sci Rep; 2021 Sep; 11(1):17844. PubMed ID: 34497315 [TBL] [Abstract][Full Text] [Related]
3. Expression of long non-coding RNA LOC285194 and its prognostic significance in human pancreatic ductal adenocarcinoma. Ding YC; Yu W; Ma C; Wang Q; Huang CS; Huang T Int J Clin Exp Pathol; 2014; 7(11):8065-70. PubMed ID: 25550852 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNAs expressed in pancreatic ductal adenocarcinoma and lncRNA BC008363 an independent prognostic factor in PDAC. Li J; Liu D; Hua R; Zhang J; Liu W; Huo Y; Cheng Y; Hong J; Sun Y Pancreatology; 2014; 14(5):385-90. PubMed ID: 25200694 [TBL] [Abstract][Full Text] [Related]
5. LncRNA co-expression network analysis reveals novel biomarkers for pancreatic cancer. Giulietti M; Righetti A; Principato G; Piva F Carcinogenesis; 2018 Jul; 39(8):1016-1025. PubMed ID: 29796634 [TBL] [Abstract][Full Text] [Related]
6. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer. Zhou M; Diao Z; Yue X; Chen Y; Zhao H; Cheng L; Sun J Oncotarget; 2016 Aug; 7(35):56383-56394. PubMed ID: 27487139 [TBL] [Abstract][Full Text] [Related]
7. Analysis of long non-coding RNA expression profiles in pancreatic ductal adenocarcinoma. Fu XL; Liu DJ; Yan TT; Yang JY; Yang MW; Li J; Huo YM; Liu W; Zhang JF; Hong J; Hua R; Chen HY; Sun YW Sci Rep; 2016 Sep; 6():33535. PubMed ID: 27628540 [TBL] [Abstract][Full Text] [Related]
8. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma. Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360 [TBL] [Abstract][Full Text] [Related]
9. LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer. Sun Y; Zhu Q; Yang W; Shan Y; Yu Z; Zhang Q; Wu H J Cell Biochem; 2019 Mar; 120(3):3874-3886. PubMed ID: 30474270 [TBL] [Abstract][Full Text] [Related]
10. Orchestrating a biomarker panel with lncRNAs and mRNAs for predicting survival in pancreatic ductal adenocarcinoma. Wu Y; Wei J; Ming Y; Chen Z; Yu J; Mao R; Chen H; Zhou G; Fan Y J Cell Biochem; 2018 Sep; 119(9):7696-7706. PubMed ID: 29923223 [TBL] [Abstract][Full Text] [Related]
11. LncRNA PWAR6 regulates proliferation and migration by epigenetically silencing YAP1 in tumorigenesis of pancreatic ductal adenocarcinoma. Huang S; Li Y; Hu J; Li L; Liu Z; Guo H; Jiang B; Chen J; Li J; Xiang X; Deng J; Xiong J J Cell Mol Med; 2021 May; 25(9):4275-4286. PubMed ID: 33834618 [TBL] [Abstract][Full Text] [Related]
12. A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma. Yang H; Zhang W; Ding J; Hu J; Sun Y; Peng W; Chu Y; Xie L; Mei Z; Shao Z; Xiao Y Front Immunol; 2022; 13():970588. PubMed ID: 36148233 [TBL] [Abstract][Full Text] [Related]
13. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer. Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma. Yuan H; Liu J; Zhao L; Wu P; Chen G; Chen Q; Shen P; Yang T; Fan S; Xiao B; Jiang K Front Immunol; 2021; 12():800268. PubMed ID: 34956238 [TBL] [Abstract][Full Text] [Related]
15. Identification of key lncRNAs in the tumorigenesis of intraductal pancreatic mucinous neoplasm by coexpression network analysis. Ding J; Li Y; Zhang Y; Fan B; Li Q; Zhang J; Zhang J Cancer Med; 2020 Jun; 9(11):3840-3851. PubMed ID: 32239802 [TBL] [Abstract][Full Text] [Related]
16. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
17. Novel three‑lncRNA signature predicts survival in patients with pancreatic cancer. Wu B; Wang K; Fei J; Bao Y; Wang X; Song Z; Chen F; Gao J; Zhong Z Oncol Rep; 2018 Dec; 40(6):3427-3437. PubMed ID: 30542694 [TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues. Liu JH; Chen G; Dang YW; Li CJ; Luo DZ Asian Pac J Cancer Prev; 2014; 15(7):2971-7. PubMed ID: 24815433 [TBL] [Abstract][Full Text] [Related]
19. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients. Fan Q; Liu B J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531 [TBL] [Abstract][Full Text] [Related]
20. High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma. Ye Y; Chen J; Zhou Y; Fu Z; Zhou Q; Wang Y; Gao W; Zheng S; Zhao X; Chen T; Chen R J Transl Med; 2015 Apr; 13():137. PubMed ID: 25925763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]